EVR Research LP Purchases New Shares in UFP Technologies, Inc. (NASDAQ:UFPT)

EVR Research LP purchased a new position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 18,000 shares of the industrial products company's stock, valued at approximately $4,401,000. UFP Technologies accounts for approximately 1.5% of EVR Research LP's investment portfolio, making the stock its 21st biggest holding. EVR Research LP owned approximately 0.23% of UFP Technologies as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Boston Trust Walden Corp acquired a new position in shares of UFP Technologies in the fourth quarter valued at about $26,395,000. Raymond James Financial Inc. acquired a new position in shares of UFP Technologies during the 4th quarter worth approximately $16,808,000. Franklin Resources Inc. lifted its position in shares of UFP Technologies by 48.1% during the 4th quarter. Franklin Resources Inc. now owns 136,345 shares of the industrial products company's stock valued at $33,338,000 after buying an additional 44,292 shares in the last quarter. Congress Asset Management Co. grew its stake in UFP Technologies by 14.2% in the 4th quarter. Congress Asset Management Co. now owns 281,325 shares of the industrial products company's stock valued at $68,787,000 after acquiring an additional 35,022 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in UFP Technologies by 340.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 39,304 shares of the industrial products company's stock valued at $9,610,000 after purchasing an additional 30,372 shares in the last quarter. 87.28% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on UFPT. Raymond James began coverage on UFP Technologies in a research note on Friday, March 28th. They issued a "market perform" rating for the company. StockNews.com lowered shares of UFP Technologies from a "hold" rating to a "sell" rating in a research report on Thursday, January 23rd.

UFP Technologies Trading Up 2.5 %

NASDAQ:UFPT traded up $5.06 on Thursday, reaching $210.51. 30,047 shares of the company's stock were exchanged, compared to its average volume of 78,632. The firm has a market capitalization of $1.62 billion, a price-to-earnings ratio of 30.03 and a beta of 1.08. UFP Technologies, Inc. has a 52-week low of $178.26 and a 52-week high of $366.41. The company has a quick ratio of 1.43, a current ratio of 2.57 and a debt-to-equity ratio of 0.64. The business has a fifty day moving average of $220.79 and a 200-day moving average of $261.30.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last posted its earnings results on Tuesday, February 25th. The industrial products company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.01 by $0.45. The firm had revenue of $144.07 million for the quarter, compared to analyst estimates of $141.67 million. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%.

Insiders Place Their Bets

In other news, Director Daniel C. Croteau sold 6,846 shares of the firm's stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the completion of the transaction, the director now directly owns 1,785 shares of the company's stock, valued at $407,711.85. This trade represents a 79.32 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 6.17% of the stock is owned by insiders.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.